REAL-TIME GLOBAL RESEARCH
Cochlear Ltd (COH.AX): 4% underlying NPAT beat but flat CI revenue growth for FY26
Research evidence excerpt
Flash |
17 Aug 2026 18:22:29 ET │ 11 pages
Cochlear Ltd (COH.AX)
4% underlying NPAT beat but flat CI revenue growth for FY26
CITI'S TAKE
COH's FY26 result was a 4% beat to VA consensus at NPAT level with flat
cochlear implant (CI) revenue yoy in constant currency terms and NPAT
margin (as expected) well below the target 18% at 13.7%. CI sales were
+5% for the FY which meant a slow down of in 2H although not as much
as we had expected. Consensus is close to the middle of the FY27
guidance range but slightly above the outlook for CC sales growth. Given
top line drag has so far come from(Western Europe revenue was -8%) we
expect investors to focus on the shape of demand for the next 1-2 years.
Key numbers —
Total revenue (incl hedging): AUD2,348m, flat YoY (+2% CC), in-line with VA
consensus.
Implant sales: AUD1.435m, -2% YoY (flat CC), in-line with VA consensus.
Implant units sold +5% YoY, 3% ahead of VA consensus.
Services sales: AUD635m, +4% YoY (+6% CC), in-line with VA consensus.
Acoustics sales: AUD273m, -1% YoY (+1% CC), 3% below VA consensus.
Gross margin: 70.5%, 320 bps lower YoY, 100 bps below VA consensus.
Underlying NPAT: AUD322m, -22% YoY, 4% ahead of VA consensus.
Sell
Price (17 Aug 26 16:00)
A$131.25
Target price
A$100.00
Expected share price return
-23.8%
Expected dividend yield
3.0%
Expected total return
-20.8%
Market Cap
A$8,584M
US$6,099M
Laura Sutcliffe, Ph.D.AC
Abhishek Jain
FY27 guidance — For FY27 COH expects low single digit CC revenue growth which
is a little ahead of consensus (we estimate consensus is at +6%CC) and underlying
NPAT of AUD330-350m (consensus is in the middle of the range).
Implications — We expect focus on the top line, including the drivers that have
made for flat CI revenue growth for FY26. The longer term 10% revenue growth goal
still looks in question to us (consensus estimates are below for the mid to long term
at the moment).
COH.AU revisions (Y/E Jun)
2024A
2025A
2026E
2027E
2028E
Sales (A$m)
% revision
EBIT (A$m)
% revision
Core Net Profit (A$m)
% revision
Core EPS (A¢)
% revision
EPS Growth (%)
PE Ratio (x)
Dividend Yield (%)
2,235.6
0.0%
504.8
0.0%
386.6
0.0%
588.2
0.0%
27.0
22.3
3.1
2,343.1
0.0%
521.3
0.0%
391.6
…
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer